OPERF
IRWD icon

Oregon Public Employees Retirement Fund’s Ironwood Pharmaceuticals IRWD Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-33,150
Closed -$147K – 1514
2024
Q4 		$147K Buy
33,150
+100
+0.3% +$406 ﹤0.01% 1466
2024
Q3 		$136K Sell
33,050
-900
-3% -$4.84K ﹤0.01% 1478
2024
Q2 		$221K Sell
33,950
-2,800
-8% -$19.8K ﹤0.01% 1367
2024
Q1 		$320K Sell
36,750
-3,366
-8% -$40.8K 0.01% 1305
2023
Q4 		$459K Sell
40,116
-700
-2% -$6.92K 0.01% 1249
2023
Q3 		$393K Sell
40,816
-1,300
-3% -$12.7K 0.01% 1367
2023
Q2 		$448K Sell
42,116
-800
-2% -$8.6K 0.01% 1351
2023
Q1 		$451K Sell
42,916
-1,372
-3% -$15.4K 0.01% 1344
2022
Q4 		$549K Buy
44,288
+26
+0.1% +$295 0.01% 1261
2022
Q3 		$459K Sell
44,262
-3,151
-7% -$35.7K 0.01% 1294
2022
Q2 		$547K Buy
+47,413
New +$559K 0.01% 1083

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Oregon Public Employees Retirement Fund's IRWD Position: Q1 2025 in Review

Oregon Public Employees Retirement Fund sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 33,150 shares — an estimated $147K sold.

Oregon Public Employees Retirement Fund first reported a position in IRWD in Q2 2022 and held it in 11 quarters. The position peaked at $549K in Q4 2022. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Oregon Public Employees Retirement Fund reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Oregon Public Employees Retirement Fund sold 33,150 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $147K.
  • Oregon Public Employees Retirement Fund first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 11 quarters.
  • Oregon Public Employees Retirement Fund's Ironwood Pharmaceuticals position peaked at $549K in Q4 2022.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q1 2025, filed 28 Apr 2025.